Lymphatic Drainage Therapy for Sleep Apnea
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to investigate whether enhancing systemic lymphatic drainage improves glymphatic function in patients with obstructive sleep apnea (OSA).
Who Is on the Research Team?
Diego Zaquera Carvalho, M.D., M.S.
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for people aged 50 or older with obstructive sleep apnea who have been using CPAP therapy successfully and consistently for at least 6 months. Participants must be willing to use an automated lymphatic drainage device nightly for a month and do home sleep monitoring. They should also be on stable medication regimens for other health issues.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo nightly Automated Manual Lymphatic Drainage Therapy (AMLDT) for one month
Follow-up
Participants are monitored for changes in sleep architecture and serum biomarkers
What Are the Treatments Tested in This Trial?
Interventions
- Automated Manual Lymphatic Drainage Therapy
Trial Overview
The study tests if an Automated Manual Lymphatic Drainage Therapy (AMLDT) device, used nightly, can improve the brain's waste clearance system in patients with obstructive sleep apnea. The research aims to see if better lymphatic drainage leads to improved brain function.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Open-Label intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.